MARKET

GILD

GILD

Gilead Sciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

67.08
+0.15
+0.22%
After Hours: 67.08 0 0.00% 17:04 12/10 EST
OPEN
66.85
PREV CLOSE
66.93
HIGH
67.18
LOW
66.13
VOLUME
4.27M
TURNOVER
--
52 WEEK HIGH
70.50
52 WEEK LOW
60.32
MARKET CAP
84.87B
P/E (TTM)
31.86
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GILD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 28 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GILD News

  • Genfit Hopes to Buck the Odds With NASH Drug
  • GuruFocus.com.2h ago
  • Fate (FATE) Announces Encouraging Data on Immunotherapies
  • Zacks.8h ago
  • No CRISPR Required: This Forgotten Gene Editing is Up 50% in 5 Weeks
  • MotleyFool.com.1d ago
  • Kite Presents Positive Results From Pivotal ZUMA-2 Trial in Relapsed or Refractory Mantle Cell Lymphoma
  • Business Wire.1d ago

More

Industry

Biotechnology & Medical Research
+0.51%
Pharmaceuticals & Medical Research
-0.29%

Hot Stocks

Name
Price
%Change

About GILD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
More

Webull offers Gilead Sciences, Inc. (GILD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.